Disease Information & Support


The Word:


Generic name Anagrelide hydrochloride
Pronunciation an-AH-gre-lide  HYE-droe-KLOR-ide
Brand name(s), other common name(s) Agrylin®
Drug type  Platelet-reducing agent
How the drug is given By mouth

Anagrelide hydrochloride is FDA approved for the treatment of patients with thrombocythemia, secondary to myeloproliferative disorders, to reduce the elevated platelet count and the risk of thrombosis and to improve associated symptoms including thrombo-hemorrhagic events (a process that involves either a blood clot or bleeding, such as a heart attack or stroke).

Side effects needing medical attention: Lack of strength; headache; fever; malaise; pain; abdominal pain; palpitations; faster than normal heartbeat; anorexia; diarrhea; indigestion; flatulence; nausea; vomiting; edema; dizziness; paresthesia (a skin sensation, such as burning, prickling, itching, or tingling, with no apparent physical cause); cough; shortness of breath; sore throat; itchy skin; rash.


For information on how to manage the costs of drug therapy, please see Financial Matters and Prescription Drug Coverage, or to speak with an Information Specialist, call (800) 955-4572.

last updated on Friday, October 12, 2012